Call toll-free 800.328.1267
Biotechnology stocks are ripping in 2019, fueled by some high-profile takeovers. It was only the second trading session of the year that Bristol Myers Squibb (BMY) gobbled up Celgene (CELG) in a record $74 billion deal. Loxo Oncology (LOXO) accepted an $8 billion bid...
Big growth stocks are roaring back to life as earnings approach. Companies like Netflix (NFLX), Incyte (INCY), Broadcom (AVGO), Facebook (FB) and Alphabet (GOOGL) are leading the S&P 500 higher today as investors return to the most important part of the market....
Suddenly small is beautiful in the eyes of investors. Indexes focused on smaller companies, like the Russell 2000 (IWM) or the Nasdaq Composite ($COMPX), have outperformed larger benchmarks like the S&P 500 ($SPX.X) and Dow Jones Industrial Average ($INDU) since...
No, it wasn't a nightmare. There was a lot of bad news on a lot of companies last week. At least five of the 30 members of the Dow Jones Industrial Average dropped amid some kind of bearish headline: Apple (AAPL): Wall Street analysts continued to hammer the...
Everyone's been focused on the selloff in tech, but something more bullish may be happening in a forgotten corner of the market. Large pharmaceutical companies including Pfizer (PFE), Merck (MRK) and Amgen (AMGN) have formed triangles in recent weeks. The...
Cannabis stocks, all the rage in September, just issued their results. And they're spending a ton of money. Just look at Tilray (TLRY), which rose more than a 1,000 percent after going public in the heart of the marijuana frenzy. Its revenue from growing pot rose 85...
Less than a week after the mid-term elections, health-care stocks have emerged as winners. Health care was a top issue ahead of the election, with voters demanding a response to drug prices and the cost of care. Maybe that's why stocks in the sector had their best day...
Stocks are enjoying a healthy rally today as the uncertainty of mid-term elections fades. With so much going on, let's just hit on a few key takeaways. First, health care is leading the rally after Democrats won a majority in the House of Representatives for the first...
A handful of big companies announced strong results in the last week, but wider problems are tarnishing the story. Feeble semiconductor demand, doubts about the industrial sector and lackluster guidance emerged as recurring themes as we progress through the busiest...